Xtant Medical Holdings Inc (XTNT)
1.105
-0.04
(-3.91%)
USD |
NYAM |
Oct 03, 16:00
1.105
0.00 (0.00%)
After-Hours: 20:00
Xtant Medical Holdings SG&A Expense (Quarterly): 13.67M for June 30, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
June 30, 2023 | 13.67M |
March 31, 2023 | 11.94M |
December 31, 2022 | 9.798M |
September 30, 2022 | 9.567M |
June 30, 2022 | 9.433M |
March 31, 2022 | 9.178M |
December 31, 2021 | 9.455M |
September 30, 2021 | 8.374M |
June 30, 2021 | 9.763M |
March 31, 2021 | 7.882M |
December 31, 2020 | 8.615M |
September 30, 2020 | 8.312M |
June 30, 2020 | 6.826M |
March 31, 2020 | 10.73M |
December 31, 2019 | 11.47M |
September 30, 2019 | 10.91M |
June 30, 2019 | 10.26M |
March 31, 2019 | 11.22M |
December 31, 2018 | 10.99M |
September 30, 2018 | 10.97M |
June 30, 2018 | 12.04M |
March 31, 2018 | 11.74M |
December 31, 2017 | 12.60M |
September 30, 2017 | 12.21M |
June 30, 2017 | 15.76M |
Date | Value |
---|---|
March 31, 2017 | 15.27M |
December 31, 2016 | 16.49M |
September 30, 2016 | 15.17M |
June 30, 2016 | 14.37M |
March 31, 2016 | 14.05M |
December 31, 2015 | 14.80M |
September 30, 2015 | 12.46M |
June 30, 2015 | 7.509M |
March 31, 2015 | 7.206M |
December 31, 2014 | 6.800M |
September 30, 2014 | 6.249M |
June 30, 2014 | 6.521M |
March 31, 2014 | 6.364M |
December 31, 2013 | 6.494M |
September 30, 2013 | 6.823M |
June 30, 2013 | 6.291M |
March 31, 2013 | 6.340M |
December 31, 2012 | 8.005M |
September 30, 2012 | 5.978M |
June 30, 2012 | 6.131M |
March 31, 2012 | 7.065M |
December 31, 2011 | 6.582M |
September 30, 2011 | 7.667M |
June 30, 2011 | 5.984M |
March 31, 2011 | 6.897M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
6.826M
Minimum
Jun 2020
13.67M
Maximum
Jun 2023
9.916M
Average
9.763M
Median
Jun 2021
SG&A Expense (Quarterly) Benchmarks
Perspective Therapeutics Inc | 5.984M |
Retractable Technologies Inc | 5.271M |
InfuSystems Holdings Inc | 15.01M |
Asensus Surgical Inc | 9.573M |
Catheter Precision Inc | 10.23M |